The FDA Just Approved Another Promising Immunotherapy for Cancer – Gizmodo
Gizmodo |
The FDA Just Approved Another Promising Immunotherapy for Cancer
Gizmodo The FDA's approval of Yescarta, manufactured by Kite Pharma, comes just a few months after its first approval—an indication of just how quickly the field of immunotherapy is moving. Several other companies also have CAR-T therapies in the works. Cutting-edge immunotherapy treatment approved for another deadly cancer Gilead cancer immunotherapy wins US approval with $373000 price F.D.A. Approves Second Gene-Altering Treatment for Cancer – The … |
